As one example, the model simulation of the changes in pharmacokinetics for morbidly obese subjects is discussed.
Pharmacodynamic models of the change in tumor size over time have been used recently to quantify the effects of therapy on solid tumors [ 18, 19].
Fear-conditioned rodents may offer an attractive model of the changes in sleep that characterize PTSD.
Finally, to construct a predictive model of the changes observed, a projection by principal component analysis (PCA) was carried out.
Indeed, more accurate modeling of the changes in receptor numbers and location is a top priority for future research because of the significant potential impact of these spatial dynamics on gradient-sensing and response.
Using various systems biology approaches to integrate expression profiling with histological data, we provide a model of the changes occurring during an episode of AOM.
Second, the study provides empirical evidence to support a contingency view of the dominance and sequencing of the different process models of change across the change journey.
Modeling of the change in geometry associated with erosion and the effects of erosion profiles on the fluid flow was postponed for subsequent works.
The required sample size for the analysis of the change in pain was calculated as the sample size needed in a simple linear regression model of the change in pain at 12 months on the baseline exposure.
